Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
about
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.Use of anti-TNF drug levels to optimise patient management.Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn’s Disease.
P2860
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@ast
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@en
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@nl
type
label
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@ast
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@en
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@nl
prefLabel
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@ast
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@en
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@nl
P2860
P356
P1476
Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease
@en
P2093
Konstantinos Papamichael
P2860
P304
P356
10.3748/WJG.V21.I16.4773
P407
P577
2015-04-28T00:00:00Z